Prebiotic- and Panthenol-Containing Multipurpose Healing Dermocosmetics Post-Cryotherapy for Actinic Keratoses: Results of a Randomized Controlled Trial

Cesare Ariasi; Carola Romanò; Cesare Tomasi; Simone Soglia; Gaetano Licata; Luca Rubelli; Piergiacomo Calzavara Pinton; Marina Venturini; Mariachiara Arisi

doi:10.5826/dpc.1501a4905

Prebiotic- and Panthenol-Containing Multipurpose Healing Dermocosmetics Post-Cryotherapy for Actinic Keratoses: Results of a Randomized Controlled Trial

Authors

Cesare Ariasi Department of Dermatology, University of Brescia, Brescia, Italy
Carola Romanò Department of Dermatology, University of Brescia, Brescia, Italy
Cesare Tomasi Department of Dermatology, University of Brescia, Brescia, Italy
Simone Soglia Department of Dermatology, University of Brescia, Brescia, Italy
Gaetano Licata Department of Dermatology, San Antonio Abate Hospital, Trapani, Italy
Luca Rubelli Department of Dermatology, University of Brescia, Brescia, Italy
Piergiacomo Calzavara Pinton Department of Dermatology, University of Brescia, Brescia, Italy
Marina Venturini Department of Dermatology, University of Brescia, Brescia, Italy
Mariachiara Arisi Department of Dermatology, University of Brescia, Brescia, Italy

Keywords:

Dermocosmetic formulation, Local skin reactions, Cryotherapy, Actinic keratosis

Abstract

Introduction: Actinic keratosis (AK) is a precancerous skin lesion that can progress to keratinocyte carcinoma.

Objective: The objective of the study was to evaluate the efficacy of a dermocosmetic (DC) formulation containing prebiotic active ingredients (Aqua Posae Filiformis, a complex made of ferments, sugars, plant extracts, panthenol, madecassoside, and zinc) on healing time and local skin reactions (LSR) following cryotherapy of AKs and to compare the application of DC aand boric acid 3% solution soaks (BA) vs. BA alone.

Methods: Seventy-five adult patients presenting with a maximum of 5 isolated AKS on the face and/or scalp and who underwent cryotherapy (T0) were enrolled. Post-treatment, patients initiated the application of BA only or BA followed by DC once daily for 30 days (unblinded 1:1 randomization). The evaluation of efficacy in healing time and cosmetic outcomes was assessed 30 days post-treatment (T2); LSR was evaluated 3 days post-treatment (T1).

Results: There was a gain of 4.5 days (40%) in healing time in the BA+DC group compared to the BA group, with a median time of 7 days versus 11.5 days (P<0.0005). Additionally, 50% of lesions in complete response had an excellent cosmetic outcome with BA+DC vs. 20% with BA only. The majority of patients treated with BA+DC had mild LSR vs. moderate LSR with BA, with a median value of 2 vs 3, respectively (P<0.0001).

Conclusion: The addition of a prebiotic DC significantly reduced healing time, improved cosmetic outcomes, and minimized LSR post-cryotherapy. No adverse events were reported with this treatment.

References

Ortonne JP. From actinic keratosis to squamous cell carcinoma. Br J Dermatol. 2002 Apr;146 Suppl 61:20-3. DOI: 10.1046/j.1365-2133.146.s61.6.x. PMID: 11966728.

Heppt MV, Leiter U, Steeb T, et al. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators. J Dtsch Dermatol Ges. 2020 Mar;18(3):275-294. DOI: 10.1111/ddg.14048. PMID: 32130773.

Eisen DB, Asgari MM, Bennett DD, et al. Guidelines of care for the management of actinic keratosis: Executive summary. J Am Acad Dermatol. 2021 Oct;85(4):945-955. DOI: 10.1016/j.jaad.2021.05.056. Epub 2021 Jun 7. PMID: 34111497.

Arisi M, Guasco Pisani E, Calzavara-Pinton P, et al. Cryotherapy for Actinic Keratosis: Basic Principles and Literature Review. Clin Cosmet Investig Dermatol. 2022 Mar 5;15:357-365. DOI: 10.2147/CCID.S267190. PMID: 35283641; PMCID: PMC8906699.

Cook DK, Georgouras K. Complications of cutaneous cryotherapy. Med J Aust. 1994 Aug 1;161(3):210-3. DOI: 10.5694/j.1326-5377.1994.tb127385.x. PMID: 8035726.

Roberts CD, Leaper DJ, Assadian O. The Role of Topical Antiseptic Agents Within Antimicrobial Stewardship Strategies for Prevention and Treatment of Surgical Site and Chronic Open Wound Infection. Adv Wound Care (New Rochelle). 2017 Feb 1;6(2):63-71. DOI: 10.1089/wound.2016.0701. PMID: 28224049; PMCID: PMC5286547.

Al-Smadi K, Leite-Silva VR, Filho NA, et al. Innovative Approaches for Maintaining and Enhancing Skin Health and Managing Skin Diseases through Microbiome-Targeted Strategies. Antibiotics (Basel). 2023 Dec 4;12(12):1698. DOI: 10.3390/antibiotics12121698. PMID: 38136732; PMCID: PMC10741029.

Mahe YF, Perez MJ, Tacheau C, et al. A new Vitreoscilla filiformis extract grown on spa water-enriched medium activates endogenous cutaneous antioxidant and antimicrobial defenses through a potential Toll-like receptor 2/protein kinase C, zeta transduction pathway. Clin Cosmet Investig Dermatol. 2013 Aug 30;6:191-6. DOI: 10.2147/CCID.S47324. PMID: 24039440; PMCID: PMC3770492.

Arisi M, Rossi MT, Spiazzi L, et al. A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging. J Dermatolog Treat. 2022 Jun;33(4):2250-2256. DOI: 10.1080/09546634.2021.1944594. Epub 2021 Jun 28. PMID: 34152936.

Zane C, Facchinetti E, Rossi MTet al. A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp. Br J Dermatol. 2014 May;170(5):1143-50. DOI: 10.1111/bjd.12844. PMID: 24506666.

Cranwell WC, Sinclair R. Optimising cryosurgery technique. Aust Fam Physician. 2017;46(5):270-274. PMID: 28472571.

Zielińska M, Pawłowska A, Orzeł A, et al. Wound Microbiota and Its Impact on Wound Healing. Int J Mol Sci. 2023 Dec 10;24(24):17318. DOI: 10.3390/ijms242417318. PMID: 38139146; PMCID: PMC10743523.

Seité S, Zelenkova H, Martin R. Clinical efficacy of emollients in atopic dermatitis patients - relationship with the skin microbiota modification. Clin Cosmet Investig Dermatol. 2017 Jan 12;10:25-33. DOI: 10.2147/CCID.S121910. PMID: 28138262; PMCID: PMC5238811.

Gorski J, Proksch E, Baron JM, et al. Dexpanthenol in Wound Healing after Medical and Cosmetic Interventions (Postprocedure Wound Healing). Pharmaceuticals (Basel). 2020 Jun 29;13(7):138. DOI: 10.3390/ph13070138. PMID: 32610604; PMCID: PMC7407203.

Wang H, Duan C, Keate RL, et al. Panthenol Citrate Biomaterials Accelerate Wound Healing and Restore Tissue Integrity. Adv Healthc Mater. 2023 Dec;12(31):e2301683. DOI: 10.1002/adhm.202301683. Epub 2023 Jun 25. PMID: 37327023; PMCID: PMC11468745.